MwanzoSOBI • STO
add
Swedish Orphan Biovitrum AB (publ)
Bei iliyotangulia
kr 282.20
Bei za siku
kr 278.60 - kr 288.00
Bei za mwaka
kr 251.00 - kr 354.40
Thamani ya kampuni katika soko
99.75B SEK
Wastani wa hisa zilizouzwa
elfu 380.96
Uwiano wa bei na mapato
24.92
Mgao wa faida
-
Ubadilishanaji wa msingi
STO
Habari za soko
The Motley Fool
saa 10 zilizopita
Nasdaq Stock Market Correction: Is Nvidia a Screaming Buy Right Now?
6.43%
0.95%
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (SEK) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 7.44B | 8.67% |
Matumizi ya uendeshaji wa biashara | 4.19B | 15.97% |
Mapato halisi | 1.40B | 36.16% |
Kiwango cha faida halisi | 18.79 | 25.35% |
Mapato kwa kila hisa | 3.98 | 25.16% |
EBITDA | 2.56B | -3.54% |
Asilimia ya kodi ya mapato | 3.27% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (SEK) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 1.14B | 26.11% |
Jumla ya mali | 75.44B | 1.91% |
Jumla ya dhima | 35.15B | -12.48% |
Jumla ya hisa | 40.30B | — |
hisa zilizosalia | 343.44M | — |
Uwiano wa bei na thamani | 2.41 | — |
Faida inayotokana na mali | 5.52% | — |
Faida inayotokana mtaji | 7.28% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (SEK) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 1.40B | 36.16% |
Pesa kutokana na shughuli | 1.80B | 67.63% |
Pesa kutokana na uwekezaji | -101.00M | 77.95% |
Pesa kutokana na ufadhili | -1.15B | -221.23% |
Mabadiliko halisi ya pesa taslimu | 545.00M | 141.15% |
Mtiririko huru wa pesa | 2.56B | 942.01% |
Kuhusu
Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care, based in Stockholm, Sweden.
In 2020 it had a revenue of SEK 15.261 billion and 1,509 employees. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1939
Tovuti
Wafanyakazi
1,840
